Nektar Therapeutics
NKTR· Nasdaq
Released Feb 27, 2020, after the close
10-K filed Feb 28, 2020, 59 days after period end · 0000906709-20-000004
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $33.86M | $39.83M | $95.47M | $37.45M |
| Net Income | -$112.16M | -$98.21M | -$33.83M | -$42.20M |
| EPS Diluted |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.64 |
| -$0.57 |
| -$0.21 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.